Abstract
Carriage frequencies of alleles and genotypes of polymorphic loci of inflammation genes (49A>G CTLA4, 41G>A and 87C>T PDE4D, −590C>T IL4, −308A>G TNF, 252G>A LTA, 874A>T IFNG, −509С>Т, 869T>C and 915G>C TGFB1) were determined in a sample of 200 patients diagnosed with ischemic stroke and in the control group similar in gender and age (146 individuals), all ethnic Russians. The positive association of the allele PDE4D*87C (р = 0.028) and genotype TGFB1*−509Т/Т (р = 0.02) carriage with ischemic stroke was shown. The association of the disease with the carriage of the allele PDE4D*41А (р = 0.009) in individuals under the age of 60 and with carriage of the allele IFNG*874Т (р = 0.02) in individuals older than 60 was observed among the subgroups of patients stratified by age when they suffered the stroke compared to a control group of the same age. In subgroups stratified by gender, carriage of the genotype TGFB1*915G/G (р = 0.0015) was identified as a risk factor in male patients, while no significant differences between female patients and healthy women were observed. Multilocus analysis was undertaken to search for the association of several combinations of studied gene variants with ischemic stroke. The polymorphic locus–174G>C of the IL6 gene, for which an association with the disease was previously demonstrated, was also included in this analysis. The disease-predisposing biallelic combinations include the IL6*−174G, PDE4D*87C, TGFB1*−509Т and TGFB1*915G alleles. In the subgroups stratified by gender, the allelic combinations mainly include the similar risk alleles as in the total group, while between the subgroups stratified by age (patients who suffered the first stroke at the age of 18 and no older than 60 years and older than 60 years), greater differences were observed. However, a new risk allele, LTA*252G, was identified in combination with PDE4D*41А in women. These findings demonstrate the important role of inflammation in ischemic stroke. The identified single and combined markers may be used further to determine an individual risk for ischemic stroke.
Similar content being viewed by others
Abbreviations
- CI:
-
confidence interval
- IS:
-
ischemic stroke
- OR:
-
odds ratio
- RFLP:
-
restriction fragment length polymorphism
- PCR:
-
polymerase chain reaction
- PCR-SSP:
-
sequence specific primer-polymerase chain reaction
- CTLA4:
-
cytotoxic T-lymphocyte-associated protein 4
- GWAS:
-
Genome-Wide Association Studies
- LTA:
-
lymphotoxin-alpha
- PDE4D:
-
phosphodiesterase 4D
- rs:
-
reference sequence
- TGFB1:
-
transforming growth factor beta 1
- TNF:
-
tumor necrosis factor
- LD:
-
linkage disequilibrium
References
Stakhovskaya L.V., Klochikhina O., Bogatyreva M.D., Kovalenko V.V. 2013. Epidemiology of stroke in Russia according to territorial population registry data. Zh. Nevrol. Psikhiatry im. S.S. Korsakova. 5, 4–10.
Gusev E.I., Skvortsova V.I., Kilikovskii V.V., Stakhovskaya L.V., Ayiryan N.Yu. 2006. The problem of stroke in the Russian Federation. Kachestvo Zhizni. 2, 10–14.
Jin R., Yang G., Li G. 2010. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J. Leukoc. Biol. 87, 779–789.
Tobin M.K., Bonds J.A., Minshall R.D., Pelligrino D.A., Testai F., Lazarov O. 2014. Neurogenesis and inflammation after ischemic stroke: What is known and where we go from here. J. Cerebral Blood Flow Metab. 34, 1573–1584.
Shenhar-Tsarfaty S., Assayag E.B., Bova I., Shopin L., Berliner S., Shapira I., Bornstein N.M. 2008. Early signaling of inflammation in acute ischemic stroke: Clinical and rheological implications. Thrombosis Res. 122, 167–173.
Titov B.V., Matveeva N.A., Martynov M.Yu., Favorova O.O. 2015. Ischemic stroke as a complex polygenic disease. Mol. Biol. (Moscow). 49, 195–216.
Avdonina M.A., Nasedkina T.V., Ikonnikova A.Yu., Bondarenko E.V., Slominskii P.A., Shamalov N.A., Shetova I.M., Limborskaya S.A., Zasedatelev A.S., Skvortsova V.I. 2012. Analysis of association of polymorphic gene markers F12, PON1, PON2, NOS2, PDE4D, HIF1a, GPIba, and CYP11B2 with ischemic stroke in the Russian population of central Russia. Zh. Nevrol. Psikhiatr. Im. S.S. Korsakova. 2, 51–54.
Bondarenko E.A., Slominskii P.A., Limborska S.A., Shetova I.M., Timofeev D.Yu., Skvortsova V.I. 2011. Polymorphic variants of ALOX5AP gene and the risk of acute stroke development in the Russian population. Russ. J. Genet. 47 (4), 500–503.
Parfenov M.G., Titov B.V., Sudomoina M.A., Martynov M.Yu., Favorov A.V., Ochs M.F., Gusev E.I., Favorova O.O. 2009. Genetic susceptibility to ischemic stroke in Russians. Mol. Biol. (Moscow). 43, 873–880.
Tupitsyna T.V., Bondarenko E.A., Botsina A.Yu., Shetova I.M., Limborska S.A., Skvortsova V.I., Slominskii P.A. 2010. Role of polymorphic variants of gene of inducible NO Synthase NOS2 in brain infarction in patients with acute ischemic stroke. Mol. Genet. Microbiol. Virol. 25 3, 3–7.
Bondarenko E.A., Tupitsyna T.V., Slominskii P.A., Shetova I.M., Shamalov N.A., Botsina A.Yu., Skvortsova V.I., Limborska S.A. 2010. Phosphodiesterase 4D (PDE4D) gene polymorphism in patients with acute stroke from Moscow. Russ. J. Genet. 46 6, 861–864.
Gretarsdottir S., Thorleifsson G., Reynisdottir S.T., Manolescu A., Jonsdottir S., Jonsdottir T., Gudmundsdottir T., Bjarnadottir S.M., Einarsson O.B., Gudjonsdottir H.M., Hawkins M., Gudmundsson G., Gudmundsdottir H., Andrason H., Gudmundsdottir A.S., et al. 2003. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131–138.
Gretarsdottir S., Sveinbjö rnsdottir S., Jonsson H.H., Jakobsson F., Einarsdottir E., Agnarsson U., Shkolny D., Einarsson G., Gudjonsdottir H.M., Valdimarsson E.M., Einarsson O.B., Thorgeirsson G., Hadzic R., Jonsdottir S., Reynisdottir S.T., et al. 2002. Localization of a susceptibility gene for common forms of stroke to 5q12. Am. J. Hum. Genet. 70, 593–603.
Staton J.M., Sayer M.S., Hankey G.J., Attia J., Thakkinstian A., Yi Q., Cole V.J., Baker R., Eikelboom J.W. 2006. Association between phosphodiesterase 4D gene and ischaemic stroke. J. Neurol. Neurosurg. Psychiatry. 77, 1067–1069.
Bevan S., Dichgans M., Gschwendtner A., Kuhlenbaumer G., Ringelstein E.B., Markus H.S. 2008. Variation in the PDE4D gene and ischemic stroke risk. A systematic review and meta-analysis on 5200 cases and 6600 controls. Stroke. 39, 1966–1971.
Fukumoto S., Koyama H., Hosoi M., Yamakawa K., Tanaka S., Morii H., Nishizawa Y. 1999. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ. Res. 85, 985–991.
Tilley S.L., Coffman T.M., Koller B.H. 2001. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108, 15–23.
Lusis A.J. 2000. Atherosclerosis. Nature. 407, 233–241.
Suzuki S., Tanaka K., Suzuki N. 2009. Ambivalent aspects of interleukin-6 in cerebral ischemia: Inflammatory versus neurotrophic aspects. J. Cerebr. Blood Flow Metab. 29, 464–479.
Titov B.V., Barsova R.M., Martynov M.Yu., Nikonova A.A., Favorov A.V., Gusev E.I., Favorova O.O. 2012. Polymorphic variants of the genes encoding intrleukin- 6 and fibrinogen: Risk for ischemic stroke and fibrinogen levels. Mol. Biol. (Moscow). 46, 85–93.
Lvovs D., Favorova O.O., Favorov A.V. 2012. A polygenic approach to studies on polygenic diseases. Acta Naturae. 4, 62–75.
Sambrook J., Fritsch E.F., Maniatis T. 1989. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press, 17–19.
Makarycheva O.Yu., Tsareva E.Yu., Sudomoina M.A., Kulakova O.G., Titov B.V., Bykova O.V., Gol’ tsova N.V., Kuzenkova L.M., Boiko A.N., Favorova O.O. 2011. Familial analysis of linkage and association of polymorphism in genes DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9, and TIMP1 with multiple sclerosis. Acta Naturae. 3, 91–98.
Tsareva E.Yu., Kulakova O.G., Makarycheva O.Yu., Boiko A.N., Shchur S.G., Lashch N.Yu., Popova N.F., Gusev E.I., Bashinskaya V.V., L’vov D.V., Favorov A.V., Ochs M.F., Favorova O.O. 2011. Pharmacogenomics of multiple sclerosis: Association of immune response gene polymorphisms with Copaxone treatment efficacy. Mol. Biol. (Moscow). 45, 886–893.
Sudomoina M.A., Sukhinina T.S., Barsova R.M., Favorov A.V., Shakhnovich R.M., Titov B.V., Matveeva N.A., Rybalkin I.N., Vlasik T.N., Ochs M.F., Ruda M.Ya., Favorova O.O. 2010. Complex analysis of association of inflammation gene polymorphisms with myocardial infarction. Mol. Biol. (Moscow). 44, 463–471.
Barsova R.M., Titov B.V., Matveeva N.A., Favorov A.V., Rybalkin I.N., Vlasik T.N., Tararak E.M., Sukhinina T.S., Shakhnovich R.M., Ruda M.Ya., Favorova O.O. 2012. Involvement of gene TGFB1 in the development of predisposition to myocardial infarction. Acta Naturae. 4, 76–82.
http://www.broad.mit.edu/mpg/haploview
Favorov A.V., Andreewski T.V., Sudomoina M.A., Favorova O.O., Parmigiani G., Ochs M.F. 2005. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans. Genetics. 171, 2113–2121.
http://apsampler.sourceforge.net/
Andersen K.K., Andersen Z.J., Olsen T.S. 2010. Ageand gender-specific prevalence of cardiovascular risk factors in 40 102 patients with first-ever ischemic stroke: A nationwide Danish study. Stroke. 41, 2768–2774.
Rosengren A., Giang K.W., Lappas G., Jern C., Toren K., Bjorck L. 2013. Twenty-four-year trends in the incidence of ischemic stroke in Sweden from 1987 to 2010. Stroke. 44, 2388–2393.
Traylor M., Rutten-Jacobs L.C., Holliday E.G., Malik R., Sudlow C., Rothwell P.M., Maguire J.M., Koblar S.A., Bevan S., Boncoraglio G., Dichgans M., Levi C., Lewis C.M., Markus H.S. 2015. Differences in common genetic predisposition to ischemic stroke by age and sex. Stroke. 46. 3042–3047.
Kuhlenbäumer G., Berger K., Huge A., Lange E., Kessler C., John U., Funke H., Nabavi D.G., Stögbauer F., Ringelstein E.B., Stoll M. 2006. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort. J. Neurol. Neurosurg. Psychiatry. 77, 521–524.
Sun Y., Huang Y., Chen X., Liu Y., Lu X., Shi Y., Tang W., Yang J., Chen W., Zhao X., Gao L., Li S., Feng G., He L. 2009. Association between the PDE4D gene and ischaemic stroke in the Chinese Han population. Clinic. Sci. (London). 117, 265–272.
Peng Z., Zhan L., Chen S., Xu E. 2011. Aßsociation of transforming growth factor-1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: A case-control study. Lipids Health Dis. 10, 100.
Syrris P., Carter N.D., Metcalfe J.C., Kemp P.R., Grainger D.J., Kaski J.C., Crossman D.C., Francis S.E., Gunn J., Jeffery S., Heathcote K. 1998. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clinic. Sci. (London). 95, 659–667.
Sie M.P., Uitterlinden A.G., Bos M.J., Arp P.P., Breteler M.M., Koudstaal P.J., Pols H.A., Hofman A., Van Duijn C.M., Witteman J.C. 2006. TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: The Rotterdam Study. Stroke. 37, 2667–2671.
Tao H.M., Chen G.Z., Cheng G.P., Shan X.Y. 2012. The haplotype of the TGFß1 gene associated with cerebral infarction in Chinese. Can. J. Neurol. Sci. 39, 626–631.
de Bakker P.I., Yelensky R., Pe’er I., Gabriel S.B., Daly M.J., 2005. Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 37, 1217–1223.
Pravica V., Perrey C., Stevens A., Lee J.H., Hutchinson I.V. 2000. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic C Amicrosatellite marker of high IFN-gamma production. Hum. Immunol. 61, 863–866.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © B.V. Titov, N.A. Matveeva, M.Yu. Martynov, O.O. Favorova, 2016, published in Molekulyarnaya Biologiya, 2016, Vol. 50, No. 4, pp. 674–684.
Rights and permissions
About this article
Cite this article
Titov, B.V., Matveeva, N.A., Martynov, M.Y. et al. Multilocus analysis of the association of polymorphic variants of inflammation genes with ischemic stroke in Russians. Mol Biol 50, 596–605 (2016). https://doi.org/10.1134/S0026893316040142
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893316040142